At the completion of this activity, the participant will be able to:
1. Discuss potential immunotherapy targets in the treatment of malignancy in regards to the proposed mechanism of action.
2. Describe anticipated toxicities mediated by inhibition of potential immunotherapy targets
3. Identify malignancies that may benefit from potential new immunotherapy agents based upon currently available data
4. Review available literature and ongoing clinical trials investigating the efficacy of potential immunotherapy targets

Session date: 
10/25/2021 - 12:00pm to 1:00pm EDT
Location: 
WPH Conference Center & Zoom
https://highmarkhealth.zoom.us/j/97834431583
Meeting ID: 978 3443 1583
Passcode: 830100
United States
  • 1.00 ACPE Pharmacy
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Attendance

Please login or register to take this course.